Should I Buy Arca Biopharma Inc Stock? Overall, Arca Biopharma Inc stock has a Value Grade of NA, Growth Grade of F, Momentum Grade of A. Whether or not you. Logo ARCA biopharma, Inc. ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for. What is the current stock price of ARCA biopharma (ABIO)?. The current stock price of ARCA biopharma (ABIO) is $ as of August 26, Arca Biopharma traded at $ this Tuesday April 9th, increasing $ or percent since the previous trading session. Looking back, over the last four. ARCA biopharma Inc. ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M ; EPS (TTM), -$
Get the latest ARCA biopharma Inc. (ABIO) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ABIO - ARCA biopharma, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). ARCA biopharma, Inc. is traded on NASDAQ under the symbol ABIO. 2. Where is ARCA biopharma, Inc. located? ARCA biopharma, Inc. is located at Church Ranch. On Friday, ARCA Biopharma Inc (ABIO:NAQ) closed at , % below its week high of , set on May 17, week range. Today. Jan 19 Thinking of buying or selling ARCA Biopharma Inc stock that's listed in a currency different from your local one? Use our international stock ticker to. ARCA Biopharma Precision Medicine · ARCA Biopharma Precision Medicine · ARCA biopharma Announces 1-for Reverse Stock Split in Connection with the Proposed. The current price of ABIO is USD — it has increased by % in the past 24 hours. Watch ARCA biopharma, Inc. stock price performance more closely on the. ARCA biopharma Inc. (ABIO) · Financials · Upcoming Catalysts · Drug Pipeline · Options · Insider Trades · News. $ + (+ Arca Biopharma stock ($ABIO) soars on merger news. Arca Biopharma Inc (NASDAQ: ABIO) more than doubled on Wednesday after announcing a merger agreement with. For the upcoming trading day on Monday, 26th we expect ARCA biopharma to open at $, and during the day (based on 14 day Average True Range), to move between. Get the latest updates on ARCA biopharma, Inc. Common Stock (ABIO) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
On Monday 07/29/ the closing price of the ARCA biopharma Inc Registered Shs share was $ on BTT. Compared to the opening price on Monday 07/29/ on. Shares of ARCA Biopharma Inc. gained % in trading on Monday after the company said it received a Fast-Track designation from the Food and Drug. What was Arca Biopharma's price range in the past 12 months? Arca Biopharma lowest stock price was $ and its highest was $ in the past 12 months. ABIO - ARCA biopharma, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM). ARCA biopharma, Inc. NasdaqCM. REAL TIME PRICE. ARCA biopharma Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for. ARCA biopharma Announces 1-for Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics. Discover historical prices for ABIO stock on Yahoo Finance. View daily, weekly or monthly format back to when ARCA biopharma, Inc. stock was issued. Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Invest In Growth? (Simply Wall St.) Sep AM.
ARCA biopharma Inc (ABIO) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. ARCA Biopharma Inc ABIO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date05/17/24 · 52 Week Low · View ARCA biopharma (ABIO) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the. When is ARCA biopharma (NASDAQ:ABIO) reporting earnings? A. ARCA biopharma's Q3 earnings are confirmed for Wednesday, October 16, Q. ARCA biopharma Inc Similar Stocks · Market price · (%).
ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular. Hold. 0 ; Current $ ; Target $ ; Technicals Summary. Sell. Neutral. Buy. Arca Biopharma Inc is currently not in a favorable trading position (SELL).